Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pavani Chalasani

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Oncology|June 15, 2017
Optimizing Quality of Life in Patients with Hormone Receptor-Positive Metastatic Breast Cancer: Treatment Options and ConsiderationsPavani Chalasani
The Oncologist|July 25, 2013
Differential chemotherapeutic sensitivity for breast tumors with "BRCAness": a reviewPavani Chalasani, Robert Livingston
JOP : Journal of the Pancreas|May 13, 2008
Response to a third-line mitomycin C (MMC)-based chemotherapy in a patient with metastatic pancreatic adenocarcinoma carrying germline BRCA2 mutationPavani Chalasani, Sandra Kurtin, Tomislav Dragovich
ACG Case Reports Journal|October 28, 2015
Spontaneous Paraesophageal HematomaJessica Yan, Courtney Walker, Pavani Chalasani
Exploration of Targeted Anti-Tumor Therapy|September 18, 2023
Nuclear epidermal growth factor receptor as a therapeutic targetBenjamin Atwell, Pavani Chalasani, Joyce Schroeder
The American Journal of Medicine|June 24, 2010
Caring for the breast cancer survivor: a guide for primary care physiciansPavani Chalasani, Leona Downey, Alison T Stopeck
The Oncologist|September 28, 2014
A pilot study of estradiol followed by exemestane for reversing endocrine resistance in postmenopausal women with hormone receptor-positive metastatic breast cancerPavani Chalasani, Alison Stopeck, Kathryn Clarke, et al.
Molecular Pharmaceutics|November 22, 2022
Camptothesome Potentiates PD-L1 Immune Checkpoint Blockade for Improved Metastatic Triple-Negative Breast Cancer ImmunochemotherapyZhiren Wang, Leyla Estrella Cordova, Pavani Chalasani, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 25, 2020
Changes in serum estradiol levels with Estring in postmenopausal women with breast cancer treated with aromatase inhibitorsAlyssa Streff, Michele Chu-Pilli, Alison Stopeck, et al.
Journal of Digital Imaging|July 26, 2011
Quantified visual scoring of metastatic melanoma patient treatment response using computed tomography: improving on the current standardRonald H Gottlieb, Elizabeth Krupinski, Pavani Chalasani, et al.
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Oncology|June 15, 2017
Optimizing Quality of Life in Patients with Hormone Receptor-Positive Metastatic Breast Cancer: Treatment Options and ConsiderationsPavani Chalasani
The Oncologist|July 25, 2013
Differential chemotherapeutic sensitivity for breast tumors with "BRCAness": a reviewPavani Chalasani, Robert Livingston
JOP : Journal of the Pancreas|May 13, 2008
Response to a third-line mitomycin C (MMC)-based chemotherapy in a patient with metastatic pancreatic adenocarcinoma carrying germline BRCA2 mutationPavani Chalasani, Sandra Kurtin, Tomislav Dragovich
ACG Case Reports Journal|October 28, 2015
Spontaneous Paraesophageal HematomaJessica Yan, Courtney Walker, Pavani Chalasani
Exploration of Targeted Anti-Tumor Therapy|September 18, 2023
Nuclear epidermal growth factor receptor as a therapeutic targetBenjamin Atwell, Pavani Chalasani, Joyce Schroeder
The American Journal of Medicine|June 24, 2010
Caring for the breast cancer survivor: a guide for primary care physiciansPavani Chalasani, Leona Downey, Alison T Stopeck
The Oncologist|September 28, 2014
A pilot study of estradiol followed by exemestane for reversing endocrine resistance in postmenopausal women with hormone receptor-positive metastatic breast cancerPavani Chalasani, Alison Stopeck, Kathryn Clarke, et al.
Molecular Pharmaceutics|November 22, 2022
Camptothesome Potentiates PD-L1 Immune Checkpoint Blockade for Improved Metastatic Triple-Negative Breast Cancer ImmunochemotherapyZhiren Wang, Leyla Estrella Cordova, Pavani Chalasani, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 25, 2020
Changes in serum estradiol levels with Estring in postmenopausal women with breast cancer treated with aromatase inhibitorsAlyssa Streff, Michele Chu-Pilli, Alison Stopeck, et al.
Journal of Digital Imaging|July 26, 2011
Quantified visual scoring of metastatic melanoma patient treatment response using computed tomography: improving on the current standardRonald H Gottlieb, Elizabeth Krupinski, Pavani Chalasani, et al.
Pageof 6